Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 3Paraproteinemias 2Immunoglobulin Light-chain Amyloidosis 2Breast Neoplasms 2Stomach Neoplasms 1Recurrence 1Postoperative Complications 1Papillomavirus Infections 1Myelodysplastic Syndromes 1Intermittent Fasting 1Colorectal Neoplasms 1Advanced Hormone Receptor-Positive Breast Carcinoma 1

Interventions

Oxaliplatin 64pembrolizumab 48Fluorouracil 44Capecitabine 38Nivolumab 33Leucovorin 32Paclitaxel 28Trastuzumab 19Docetaxel 18Cisplatin 18S 1 (combination) 16Bevacizumab 15Ramucirumab 13Irinotecan 13Drug Therapy 13tislelizumab 12Cyclophosphamide 12fludarabine 10Carboplatin 10Radiotherapy 9Magnetic Resonance Spectroscopy 9trastuzumab deruxtecan 8sintilimab 8Specimen Handling 8Biopsy 8atezolizumab 7Surgical Procedures, Operative 7Gemcitabine 7zolbetuximab 6durvalumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Clinical Protocols × 1 year × Clear all
NCT07328633 2026-01-09

Prehabilitation Plus ERAS in Gastric Cancer Surgery

The Affiliated Hospital of Qingdao University

Phase NA Completed
136 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡